Matthew A. Spear - Jun 17, 2021 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Role
Chief Medical Officer
Signature
/s/ Johanna Mylet, Attorney-in-Fact
Stock symbol
PSTX
Transactions as of
Jun 17, 2021
Transactions value $
$6,610
Form type
4
Date filed
6/21/2021, 08:02 PM
Previous filing
Jun 14, 2021
Next filing
Jul 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Options Exercise $6.61K +5K +30.33% $1.32 21.5K Jun 17, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PSTX Stock Option (Right to Buy) Options Exercise $0 -5K -4.17% $0.00 115K Jun 17, 2021 Common Stock 5K $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested and exercisable.